Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$43.21 - $57.6 $43 - $57
-1 Reduced 0.02%
6,622 $318,000
Q3 2021

Nov 10, 2021

BUY
$52.8 - $60.32 $5,966 - $6,816
113 Added 1.74%
6,623 $368,000
Q2 2021

Aug 16, 2021

BUY
$51.29 - $59.15 $333,897 - $385,066
6,510 New
6,510 $353,000
Q2 2020

Aug 14, 2020

SELL
$31.07 - $44.74 $1 Million - $1.44 Million
-32,236 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$22.46 - $42.24 $12,959 - $24,372
-577 Reduced 1.76%
32,236 $1.07 Million
Q4 2019

Feb 13, 2020

SELL
$39.01 - $47.51 $329,400 - $401,174
-8,444 Reduced 20.47%
32,813 $1.36 Million
Q3 2019

Nov 13, 2019

SELL
$38.66 - $47.41 $2.36 Million - $2.9 Million
-61,133 Reduced 59.71%
41,257 $1.89 Million
Q2 2019

Aug 08, 2019

SELL
$38.23 - $47.43 $121,800 - $151,111
-3,186 Reduced 3.02%
102,390 $4.42 Million
Q1 2019

May 13, 2019

SELL
$41.26 - $58.35 $73,690 - $104,213
-1,786 Reduced 1.66%
105,576 $4.59 Million
Q4 2018

Feb 14, 2019

SELL
$44.93 - $73.38 $263,334 - $430,080
-5,861 Reduced 5.18%
107,362 $5.07 Million
Q3 2018

Nov 13, 2018

BUY
$56.85 - $80.35 $481,576 - $680,644
8,471 Added 8.09%
113,223 $8.45 Million
Q2 2018

Aug 13, 2018

BUY
$35.85 - $57.05 $126,478 - $201,272
3,528 Added 3.49%
104,752 $5.78 Million
Q1 2018

May 14, 2018

SELL
$27.0 - $38.5 $75,519 - $107,684
-2,797 Reduced 2.69%
101,224 $3.85 Million
Q4 2017

Feb 13, 2018

SELL
$28.0 - $33.2 $88,732 - $105,210
-3,169 Reduced 2.96%
104,021 $2.91 Million
Q3 2017

Nov 13, 2017

BUY
$24.5 - $31.1 $55,076 - $69,912
2,248 Added 2.14%
107,190 $3.32 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-249 Reduced 0.24%
104,942 $2.95 Million
Q1 2017

Apr 17, 2019

SELL
N/A
-35,779 Reduced 25.38%
105,191 $2.53 Million
Q4 2016

Apr 17, 2019

SELL
N/A
-2,940 Reduced 2.04%
140,970 $3.58 Million
Q3 2016

Apr 17, 2019

BUY
N/A
143,910
143,910 $4.33 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $397M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.